Compound ID | 847

Update compound information

RBX 8700

Class: Oxazolidinone

Spectrum of activity: Gram-negative
Details of activity: This was in preclinical trials for TB and linezolid resistant Enterococci
Institute where first reported: Ranbaxy Laboratories (Sun Pharmaceutical Industries, India)
Year first mentioned: 2004
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 463.48
Iso. SMILES: CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C4=CC=C(S4)[N+](=O)[O-])F
InChI Key: NXFHHHLDWRQIEH-HNNXBMFYSA-N
Can. SMILES: CC(=O)NC[C@H]1CN(C2=CC=C(C(=C2)F)N3CCN(CC3)C4=CC=C([N+](=O)[O-])S4)C(=O)O1
InChI: InChI=1S/C20H22FN5O5S/c1-13(27)22-11-15-12-25(20(28)31-15)14-2-3-17(16(21)10-14)23-6-8-24(9-7-23)18-4-5-19(32-18)26(29)30/h2-5,10,15H,6-9,11-12H2,1H3,(H,22,27)/t15-/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9847231
Citation:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.